Video

Dr. Sippel on the Importance of the Initial Surgery for MTC

Rebecca S. Sippel, MD, from the University of Wisconsin, discusses the importance of the initial surgery for patients with medullary thyroid cancer on outcomes.

Rebecca S. Sippel, MD, associate professor of surgery, University of Wisconsin, Madison, Wisconsin, discusses the importance of the initial surgical procedure for the management of patients with medullary thyroid cancer (MTC).

The initial surgery for MTC substantially dictates and impacts the long-term prognosis for patients. The most adequate and successful surgery requires proper preoperative diagnosis and planning, Sippel believes. Following a diagnosis by fine-needle aspiration cytology, an appropriate staging evaluation using calcitonin levels and a neck ultrasound establishes whether the disease is regional or metastatic and helps determine the extent of the surgery.

Sippel recommends a total thyroidectomy plus a comprehensive bilateral central neck dissection (CND) for every patient with MTC, at the first surgical intervention. She warns that a bilateral CND is difficult to perform in a second procedure, warranting the upfront use in every patient since nodal disease is common. However, in some cases, a lateral or ipsilateral lateral neck dissection may also be effective, she adds.

Unlike other types of thyroid cancer, surgical management is the mainstay for MTC and must be aggressive and comprehensive at the initial operation in order to achieve the best results.

<<<

View coverage from the 2012 ATA Annual Meeting

Related Videos
Jacob Sands, MD, oncology medical director, International Patient Center, Dana-Farber Cancer Institute; assistant professor, Harvard Medical School
Fred R. Hirsch, MD, PhD, executive director, Center for Thoracic Oncology, The Tisch Cancer Institute at Mount Sinai; Joe Lowe and Louis Price Professor of Medicine (Hematology and Medical Oncology), Icahn School of Medicine at Mount Sinai
Lori Wirth, MD
Marshall Posner, MD
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Leah Backhus, MD, MPH, FACS, professor, University Medical Line, Cardiothoracic Surgery, co-director, Thoracic Surgery Clinical Research Program, associate program director, Thoracic Track, CT Surgery Residency Training Program, Thelma and Henry Doelger Professor of Cardiovascular Surgery, Stanford Medicine; chief, Thoracic Surgery, VA Palo Alto
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Medical Oncology, director, Center for Thoracic Cancers, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Sheldon M. Feldman, MD
Rita Mukhtar, MD